Jane Street
AQST icon

Jane Street’s Aquestive Therapeutics AQST Stock Holding History

Jane Street’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.6K Buy
20,100
+1,100
+6% +$4.63K ﹤0.01% 10694
2026
Q1 		$78.8K Sell
19,000
-4,800
-20% -$19.5K ﹤0.01% 10754
2025
Q4 		$154K Buy
+23,800
New +$148K ﹤0.01% 9912

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Jane Street's AQST Position: Q2 2026 in Review

Jane Street reduced its Aquestive Therapeutics (AQST) stake by 58% in Q2 2026, selling an estimated $2.49M and leaving 437,490 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #5351.

Jane Street first reported a position in AQST in Q2 2019 and has held it in 17 quarters since. The position peaked at $4.27M in Q1 2026. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Jane Street held 437,490 shares of Aquestive Therapeutics worth $1.82M as of Q2 2026.
  • Jane Street sold 592,560 Aquestive Therapeutics shares in Q2 2026, an estimated $2.49M.
  • Aquestive Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5351 holding.
  • Jane Street first reported a position in Aquestive Therapeutics in Q2 2019 and has held it in 17 quarters since.
  • Jane Street's Aquestive Therapeutics position peaked at $4.27M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.